Genetic markers in lung cancer diagnosis: a review

K Wadowska, I Bil-Lula, Ł Trembecki… - International journal of …, 2020 - mdpi.com
Lung cancer is the most often diagnosed cancer in the world and the most frequent cause of
cancer death. The prognosis for lung cancer is relatively poor and 75% of patients are …

PTEN in lung cancer: dealing with the problem, building on new knowledge and turning the game around

A Gkountakos, G Sartori, I Falcone, G Piro, L Ciuffreda… - Cancers, 2019 - mdpi.com
Lung cancer is the most common malignancy and cause of cancer deaths worldwide, owing
to the dismal prognosis for most affected patients. Phosphatase and tensin homolog deleted …

An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness

L Liu, T Tao, S Liu, X Yang, X Chen, J Liang… - Nature …, 2021 - nature.com
Notch signaling represents a key mechanism mediating cancer metastasis and stemness.
To understand how Notch signaling is overactivated to couple tumor metastasis and self …

Needle biopsy adequacy in the era of precision medicine and value-based health care

KPH Pritzker, HJ Nieminen - Archives of pathology & …, 2019 - meridian.allenpress.com
Context.—Needle biopsy of diseased tissue is an essential diagnostic tool that is becoming
even more important as precision medicine develops. However, the capability of this …

A Canadian guideline on the use of next-generation sequencing in oncology

S Yip, A Christofides, S Banerji, MR Downes… - Current …, 2019 - pmc.ncbi.nlm.nih.gov
Rapid advancements in next-generation sequencing (ngs) technology have created an
unprecedented opportunity to decipher the molecular profile of tumours to more effectively …

[HTML][HTML] Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer

JY Lee, RR Bhandare, SHS Boddu, AB Shaik… - Biomedicine & …, 2024 - Elsevier
Tumour suppressor genes play a cardinal role in the development of a large array of human
cancers, including lung cancer, which is one of the most frequently diagnosed cancers …

ALK testing trends and patterns among community practices in the United States

PB Illei, W Wong, N Wu, L Chu, R Gupta… - JCO Precision …, 2018 - ascopubs.org
Purpose Targeted therapy of ALK in patients with metastatic nonsquamous non–small-cell
lung cancer (NSCLC) and ALK rearrangements improves outcomes compared with …

Rethinking Gamma-secretase Inhibitors for treatment of non–small-cell lung cancer: Is notch the target?

SR Pine - Clinical Cancer Research, 2018 - AACR
Lung cancer is the leading cause of cancer-related deaths among men and women. γ-
Secretase inhibitors, a class of small-molecule compounds that target the Notch pathway …

Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line–Indian consensus statement update (Under the aegis of Lung Cancer …

K Prabhash, A Vora, S Limaye, TP Sahoo… - Cancer Research …, 2021 - journals.lww.com
The management of patients with advanced non-small-cell lung cancer (NSCLC) is
becoming increasingly complex, with the identification of driver mutations/rearrangements …

Tissue-and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study

M Sposito, L Belluomini, R Nocini… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction To date, for all non-small cell lung cancer (NSCLC) cases, it is recommended to
test for driver alterations to identify actionable therapeutic targets. In this light …